Madan Ajay 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Feb 9, 2022
Insider Transaction Report
Form 4
Madan Ajay
Chief Development Officer
Transactions
- Sale
Common Stock
2022-02-07$17.83/sh−13,411$239,085→ 172,045 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sales prices range between $17.170 and $18.015. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.